Study of immune and genetics factors in bipolar or schizophrenia
Treatments studied
Part of Mental health clinical trials.
This study looks at how the immune system, genetics, inflammation, and past exposures may relate to bipolar disorder or schizophrenia. It may help researchers understand the cause and find better ways to support people with these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with bipolar disorder or schizophrenia (DSM-IV diagnosis).
- You are not pregnant.
- You have not had any vaccines in the last 4 weeks.
- You do not have a serious nervous system (neurologic) illness.
- You are not taking medicines that weaken or change your immune system, and you have not had an infection in the last 4 weeks (including HIV, hepatitis B, or hepatitis C).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for a biological signature in the brain and blood to help doctors tell apart different types of psychosis early on. It may help people with schizophrenia, bipolar disorder, or major depression understand their condition better.
This study is building a genetic and blood-sample database to better understand bipolar disorder. Researchers will compare people with bipolar disorder to controls to find biological clues that may improve future diagnosis and treatment.
This study looks at how immune system health relates to brain changes in people with schizophrenia. It uses brain imaging and electrical activity tests to understand these connections.
This study collects information about mental health symptoms and body/genetic samples to better understand how different mental health conditions are related. Some people may also have brain scans (PET or MRI) if they can safely complete them.
This study builds a database and collects samples (like blood) from people with schizophrenia to learn more about the condition. If you join, you help researchers understand schizophrenia better, which may lead to improved treatments.
This study looks at brain chemicals involved in “glutamate” and “GABA” signaling in people with schizophrenia (and separately in healthy volunteers). It may help researchers understand what’s going wrong in the brain and guide future treatments.
Hear when a new Bipolar Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.